发明名称 COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
摘要 Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited by the compounds described. For example, the chymotrypsin-like activity of the 20S proteasome may be selectively inhibited with the inventive compounds. The peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus. Among other therapeutic utilities, the peptide-based compounds are expected to display anti-inflammatory properties and inhibition of cell proliferation.
申请公布号 IL221572(D0) 申请公布日期 2012.10.31
申请号 IL20120221572 申请日期 2012.08.22
申请人 ONYX THERAPEUTICS, INC. 发明人
分类号 C07K5/08;C07K5/087 主分类号 C07K5/08
代理机构 代理人
主权项
地址